Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.

Search

Result:: 21-30 Hits of 42

The effect of a traditional Chinese quadri-combination therapy and its component quercetin on recurrent spontaneous abortion: A clinical trial, network pharmacology and experiments-based study

Authors:: Jing Zhou; Lisha Li; Xinyao Pan; Jing Wang; Qing Qi; Hongmei Sun; Chuyu Li; Ling Wang

Reference:: Frontiers in Pharmacology; 2022; 13; 965694

DOI:: 10.3389/fphar.2022.965694

See Abstract

Quercetin effectiveness in the complex hypolipidemic therapy of patients with nonalcoholic fatty liver disease with metabolic syndrome

Authors:: L. S. Kravchenko; O. L. Appelhans; A. E. Poliakov; I. Yu. Borysiuk; Y. I. Ivanova; N. V. Neskoromna; M. V. Rosumenko

Reference:: World of Medicine and Biology; 2022; 81; 76-82

DOI:: 10.26724/2079-8334-2022-3-81-76-82

See Abstract

Evaluation of the combination effect of rutin and vitamin C supplementation on the oxidative stress and inflammation in hemodialysis patients

Authors:: Samia Omar; Radwa Maher El Borolossy; Tamer Elsaid; Nagwa A. Sabri

Reference:: Frontiers in Pharmacology; 2022; 13; 961590

DOI:: 10.3389/fphar.2022.961590

See Abstract

Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry

Authors:: Maria R. Cesarone; Gianni Belcaro; Shu Hu; Mark Duvall; Morio Hosoi; Andrea Ledda; Beatrice Feragalli; Claudia Maione; Roberto Cotellese

Reference:: Minerva Medica; 2019; 110; 524-529

DOI:: 10.23736/S0026-4806.19.06319-5

See Abstract

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Authors:: Amjad Khan; Somia Iqtadar; Sami Ullah Mumtaz; Michael Heinrich; Domingo A. Pascual-Figal; Shona Livingstone; Sajid Abaidullah

Reference:: Frontiers in Pharmacology; 2022; 13; 898062

DOI:: 10.3389/fphar.2022.898062

See Abstract

Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial

Authors:: Mitzi M. Gonzales; V. R. Garbarino; E. Marques Zilli; R. C. Petersen; J. L. Kirkland; T. Tchkonia; N. Musi; S. Seshadri; S. Craft; Miranda E. Orr

Reference:: The Journal of Prevention of Alzheimer’s Disease; 2022; 9; 22–29

DOI:: 10.14283/jpad.2021.62

See Abstract

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Authors:: LaTonya J. Hickson; Larissa G.P. Langhi Prata; Shane A. Bobart; Tamara K. Evans; Nino Giorgadze; Shahrukh K. Hashmi; Sandra M. Herrmann; Michael D. Jensen; Qingyi Jia; Kyra L. Jordan; Todd A. Kellogg; Sundeep Khosla; Daniel M. Koerber; Anthony B. Lagnado; Donna K. Lawson; Nathan K. LeBrasseur; Lilach O. Lerman; Kathleen M. McDonald; James L. Kirkland

Reference:: eBioMedicine; 2019; 47; 446-456

DOI:: 10.1016/j.ebiom.2019.08.069

See Abstract

Effect of quercetin on the echocardiographic parameters of left ventricular diastolic function in patients with gout and essential hypertension

Authors:: Vitalii E. Kondratiuk; Yuliia P. Synytsia

Reference:: Wiadomości Lekarskie; 2018; 71; 1554-1559

DOI:: ?

See Abstract

Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial

Authors:: Ju Qiu; Yanping Liu; Yanfen Yue; Yuchang Qin; Zaigui Li

Reference:: Nutrition Research; 2016; 36; 1392-1401

DOI:: 10.1016/j.nutres.2016.11.007

See Abstract

Effect of Quercetin on CYP3A Activity in Chinese Healthy Participants

Authors:: Kai-Ming Duan; Sai-Ying Wang; Wen Ouyang; Yan-Mei Mao; Li-Jun Yang

Reference:: The Journal of Clinical Pharmacology; 2012; 52; 940-946

DOI:: 10.1177/0091270011406278

See Abstract